CURE is pleased to announce that John Burkhardt of Pfizer has joined CURE’s Board of Directors.
John is Vice President, Global Drug Safety Research and Development, Groton Labs Site Director, Pfizer. His knowledge base covers early drug discovery, late stage development, regulatory review and approval of both small and large molecules.